DegronTherapeuticsaimstobecomeagloballeaderinthediscoveryanddevelopmentofanewclassoftargetedproteindegradationtherapeutics,smallmoleculemoleculargluedegrader(MGD)drugs.Degronhasassembledateamofworld-classexecutivesandscientificleaders,bringingitsscientificexcellencetotheidentificationandvalidationofdiseasetargets,particularlythoseundruggablebyconventionalsmallmoleculeinhibitors,andnovelselectiveMGDcompoundstomeetunmetmedicalneedsinalltherapeuticareas.